These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 21035959

  • 21. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
    Lin L, Yao JJ, Zhou GQ, Guo R, Zhang F, Zhang Y, Xu L, Zhang LL, Lin AH, Ma J, Sun Y.
    Oncotarget; 2016 Apr 12; 7(15):20680-90. PubMed ID: 26980744
    [Abstract] [Full Text] [Related]

  • 22. Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era.
    Niu X, Xue F, Liu P, Hu C, He X.
    Int J Med Sci; 2022 Apr 12; 19(2):267-273. PubMed ID: 35165512
    [Abstract] [Full Text] [Related]

  • 23. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
    Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, Akazawa P, Weinberg V, Fu KK.
    Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):12-22. PubMed ID: 12007936
    [Abstract] [Full Text] [Related]

  • 24. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y, Tang LL, Chen L, Li WF, Mao YP, Liu LZ, Lin AH, Li L, Ma J.
    BMC Cancer; 2012 Feb 15; 12():68. PubMed ID: 22336097
    [Abstract] [Full Text] [Related]

  • 25. A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
    Lertbutsayanukul C, Prayongrat A, Kannarunimit D, Chakkabat C, Netsawang B, Kitpanit S.
    Strahlenther Onkol; 2018 May 15; 194(5):375-385. PubMed ID: 29302704
    [Abstract] [Full Text] [Related]

  • 26. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH, Woo SY, Cui NJ, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):682-7. PubMed ID: 14967420
    [Abstract] [Full Text] [Related]

  • 27. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
    Qiu S, Lin S, Tham IW, Pan J, Lu J, Lu JJ.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):676-83. PubMed ID: 22024207
    [Abstract] [Full Text] [Related]

  • 28. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C, Han F, Lu LX, Huang SM, Lin CG, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [Abstract] [Full Text] [Related]

  • 29. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
    Ren G, Du L, Ma L, Feng LC, Zhou GX, Qu BL, Xu SP, Xie CB, Ou GM, Li F, Zhang XX, Yang J.
    Technol Cancer Res Treat; 2011 Jun 01; 10(3):259-66. PubMed ID: 21517132
    [Abstract] [Full Text] [Related]

  • 30. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL, Huang YS, Kuo SH, Hong RL, Ko JY, Lou PJ, Wang CW.
    Oncotarget; 2017 Feb 21; 8(8):14068-14077. PubMed ID: 27764778
    [Abstract] [Full Text] [Related]

  • 31. Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
    Wu MY, He XY, Hu CS.
    PLoS One; 2016 Feb 21; 11(4):e0154501. PubMed ID: 27119991
    [Abstract] [Full Text] [Related]

  • 32. High-Dose Static and Dynamic Intensity-Modulated Radiotherapy Combined with Chemotherapy for Patients with Locally Advanced Nasopharyngeal Carcinoma Improves Survival and Reduces Brainstem Toxicity.
    Sun PY, Chen YH, Feng XB, Yang CX, Wu F, Wang RS.
    Med Sci Monit; 2018 Dec 07; 24():8849-8859. PubMed ID: 30524119
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
    Jiang F, Jin T, Feng XL, Jin QF, Chen XZ.
    J Cancer Res Ther; 2015 Oct 07; 11 Suppl 2():C179-84. PubMed ID: 26506872
    [Abstract] [Full Text] [Related]

  • 34. Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study.
    Wang J, Shi M, Hsia Y, Luo S, Zhao L, Xu M, Xiao F, Fu X, Li J, Zhou B, Long X.
    Radiat Oncol; 2012 Jan 10; 7():2. PubMed ID: 22233756
    [Abstract] [Full Text] [Related]

  • 35. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
    Zhao W, Lei H, Zhu X, Li L, Qu S, Liang X.
    Oncotarget; 2016 Dec 27; 7(52):86914-86925. PubMed ID: 27894100
    [Abstract] [Full Text] [Related]

  • 36. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
    Xu P, Min Y, Blanchard P, Feng M, Zhang P, Luo Y, Fan Z, Lang J.
    Head Neck; 2017 Feb 27; 39(2):305-310. PubMed ID: 27627795
    [Abstract] [Full Text] [Related]

  • 37. Long-term survival of nasopharyngeal carcinoma patients with Stage II in intensity-modulated radiation therapy era.
    Guo Q, Lu T, Lin S, Zong J, Chen Z, Cui X, Zhang Y, Pan J.
    Jpn J Clin Oncol; 2016 Mar 27; 46(3):241-7. PubMed ID: 26755831
    [Abstract] [Full Text] [Related]

  • 38. Long-term survival and late complications in intensity-modulated radiotherapy of locally recurrent T1 to T2 nasopharyngeal carcinoma.
    Tian YM, Guan Y, Xiao WW, Zeng L, Liu S, Lu TX, Zhao C, Han F.
    Head Neck; 2016 Feb 27; 38(2):225-31. PubMed ID: 25244494
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.
    Qiu S, Lu J, Zheng W, Xu L, Lin S, Huang C, Xu Y, Huang L, Pan J.
    BMC Cancer; 2014 Nov 03; 14():797. PubMed ID: 25366703
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.